PPARA and metabolic dysfunction-associated steatotic liver disease: Our previous studies also exhibited that the ingredients of spleen-tonifying drugs can improve NAFLD or NASH by regulating PPAR signaling, which indirectly confirms the conclusion of this topic (36, 37).